We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL31 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
1964.5
Number of samples
349
Samples
Sample
Description
pTPM
TCGA-WR-A838-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 304 days
7111.8
TCGA-25-1877-01A
81 years, female, white, stage:Stage IIIC, dead, 730 days
5685.3
TCGA-04-1347-01A
81 years, female, white, stage:Stage IV, alive, 1919 days
5420.8
TCGA-25-2393-01A
81 years, female, white, stage:Stage IIIC, dead, 1157 days
5249.5
TCGA-25-1634-01A
75 years, female, white, stage:Stage IIIC, dead, 1091 days
5129.2
TCGA-30-1714-01A
68 years, female, white, stage:Stage IV, dead, 1158 days
5060.5
TCGA-04-1350-01A
46 years, female, white, stage:Stage IIIC, dead, 1946 days
5020.5
TCGA-23-1107-01A
59 years, female, white, stage:Stage IV, dead, 9 days
5014.0
TCGA-04-1655-01A
49 years, female, white, stage:Stage IIIB, dead, 1380 days
4691.2
TCGA-30-1891-01A
61 years, female, white, stage:Stage IIIC, dead, 914 days
4587.6
TCGA-10-0927-01A
65 years, female, stage:Stage IIIC, dead, 2490 days
4503.3
TCGA-29-1701-01A
56 years, female, white, stage:Stage IIIC, dead, 515 days
4454.9
TCGA-29-2425-01A
60 years, female, white, stage:Stage IIIC, alive, 1977 days
4396.6
TCGA-61-1721-01A
38 years, female, white, stage:Stage IV, alive, 338 days
4230.4
TCGA-29-1777-01A
47 years, female, white, stage:Stage IIIC, alive, 374 days
4153.4
TCGA-24-1471-01A
60 years, female, white, stage:Stage IIIC, alive, 36 days
4106.5
TCGA-24-2038-01A
68 years, female, white, stage:Stage IIIA, dead, 1354 days
3998.2
TCGA-23-1113-01A
48 years, female, white, stage:Stage IV, dead, 949 days
3919.8
TCGA-29-1703-01A
56 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
3918.6
TCGA-24-0966-01A
78 years, female, black or african american, stage:Stage IIIC, alive, 232 days
3895.9
TCGA-13-0887-01A
42 years, female, white, stage:Stage IIIC, dead, 2028 days
3853.7
TCGA-29-1696-01A
43 years, female, white, stage:Stage IIIC, dead, 1032 days
3847.3
TCGA-29-1768-01A
50 years, female, white, stage:Stage IV, dead, 952 days
3834.9
TCGA-13-1409-01A
73 years, female, white, stage:Stage IIIC, dead, 1742 days
3733.5
TCGA-24-1553-01A
53 years, female, white, stage:Stage IIIB, dead, 1767 days
3729.0
TCGA-13-1507-01A
77 years, female, white, stage:Stage IIIC, dead, 1993 days
3718.1
TCGA-30-1718-01A
44 years, female, white, stage:Stage IIIC, dead, 1579 days
3711.9
TCGA-04-1341-01A
85 years, female, white, stage:'--, alive, 33 days
3709.3
TCGA-09-1666-01A
57 years, female, white, stage:Stage IIIC, alive, 1752 days
3665.4
TCGA-13-0765-01A
50 years, female, white, stage:Stage IIIC, dead, 1389 days
3658.1
TCGA-13-0885-01A
70 years, female, white, stage:Stage IIIC, alive, 3388 days
3647.7
TCGA-24-1544-01A
71 years, female, black or african american, stage:Stage IIIC, dead, 820 days
3640.5
TCGA-25-1316-01A
55 years, female, white, stage:Stage IIIC, dead, 1279 days
3632.9
TCGA-61-2110-01A
56 years, female, white, stage:Stage IIIC, dead, 1354 days
3539.0
TCGA-29-1769-01A
40 years, female, white, stage:Stage IIIC, alive, 699 days
3494.1
TCGA-29-1761-01A
80 years, female, asian, stage:Stage IIIC, dead, 528 days
3423.1
TCGA-23-1022-01A
67 years, female, white, stage:Stage IIIC, dead, 1511 days
3417.6
TCGA-10-0937-01A
44 years, female, white, stage:Stage IIIC, dead, 608 days
3398.2
TCGA-5X-AA5U-01A
61 years, female, black or african american, stage:Stage IIC, alive, 361 days
3356.3
TCGA-13-0724-01A
72 years, female, white, stage:Stage IV, dead, 83 days
3341.2
TCGA-25-1630-01A
73 years, female, white, stage:Stage IIIC, dead, 1162 days
3200.6
TCGA-59-2363-01A
40 years, female, asian, stage:Stage IIIA, alive, 165 days
3174.3
TCGA-13-1489-01A
70 years, female, white, stage:Stage IIIC, dead, 2553 days
3161.9
TCGA-10-0931-01A
44 years, female, white, stage:Stage IIIC, dead, 1000 days
3155.8
TCGA-13-0923-01A
74 years, female, white, stage:Stage IIIC, alive, 2547 days
3084.4
TCGA-13-0766-01A
42 years, female, white, stage:Stage IIIC, dead, 1725 days
3068.0
TCGA-10-0938-01A
80 years, female, white, stage:Stage IIIC, dead, 636 days
3046.6
TCGA-13-0762-01A
65 years, female, white, stage:Stage IIIC, alive, 3400 days
3039.9
TCGA-29-1766-01A
74 years, female, white, stage:Stage IIIC, dead, 1199 days
3037.1
TCGA-09-0367-01A
67 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
3015.3
TCGA-24-1562-01A
67 years, female, white, stage:Stage IIIC, dead, 1384 days
2987.9
TCGA-25-1632-01A
68 years, female, white, stage:Stage IV, dead, 1799 days
2944.7
TCGA-24-1616-01A
56 years, female, white, stage:Stage IIIC, dead, 1163 days
2916.8
TCGA-13-1487-01A
74 years, female, white, stage:Stage IV, dead, 681 days
2910.4
TCGA-13-0795-01A
66 years, female, white, stage:Stage IIIC, dead, 619 days
2886.1
TCGA-13-A5FT-01A
67 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
2843.3
TCGA-25-1633-01A
64 years, female, white, stage:Stage IIIC, dead, 1891 days
2842.2
TCGA-25-1317-01A
66 years, female, white, stage:Stage IIIC, dead, 61 days
2833.0
TCGA-OY-A56Q-01A
78 years, female, black or african american, stage:Stage IIA, alive, 576 days
2830.1
TCGA-23-1027-01A
48 years, female, white, stage:Stage IIIC, dead, 976 days
2801.6
TCGA-24-1560-01A
51 years, female, white, stage:Stage IIIC, dead, 1341 days
2793.7
TCGA-29-1690-01A
66 years, female, white, stage:Stage IIIC, dead, 1448 days
2787.1
TCGA-30-1853-01A
58 years, female, white, stage:Stage IIIC, dead, 1103 days
2772.3
TCGA-09-1670-01A
57 years, female, white, stage:Stage IIIA, alive, 547 days
2731.4
TCGA-24-1842-01A
49 years, female, white, stage:Stage IIIC, alive, 253 days
2730.4
TCGA-VG-A8LO-01A
55 years, female, black or african american, stage:Stage IV, dead, 24 days
2729.8
TCGA-13-1505-01A
63 years, female, white, stage:Stage IIIC, alive, 1998 days
2714.9
TCGA-13-0924-01A
45 years, female, white, stage:Stage IV, alive, 2614 days
2708.3
TCGA-13-0883-01A
61 years, female, white, stage:Stage IIIC, dead, 2097 days
2699.0
TCGA-13-0804-01A
73 years, female, white, stage:Stage IIIC, dead, 1073 days
2692.8
TCGA-61-1725-01A
40 years, female, white, stage:Stage IIIC, alive, 956 days
2688.6
TCGA-29-2414-01A
75 years, female, white, stage:Stage IIIC, dead, 2621 days
2681.2
TCGA-36-1569-01A
52 years, female, white, stage:Stage IIIC, alive, 885 days
2654.2
TCGA-13-0727-01A
71 years, female, white, stage:Stage IIIC, dead, 462 days
2647.4
TCGA-04-1343-01A
72 years, female, white, stage:Stage IV, dead, 361 days
2635.4
TCGA-30-1862-01A
65 years, female, white, stage:Stage IV, dead, 186 days
2628.8
TCGA-04-1356-01A
62 years, female, white, stage:Stage IIC, dead, 1499 days
2570.6
TCGA-25-2400-01A
76 years, female, white, stage:Stage IIIC, dead, 1278 days
2565.1
TCGA-61-1728-01A
59 years, female, white, stage:Stage IV, alive, 848 days
2563.8
TCGA-24-1923-01A
51 years, female, white, stage:Stage IIIC, dead, 690 days
2558.5
TCGA-23-1111-01A
63 years, female, white, stage:Stage IIIC, alive, 98 days
2530.2
TCGA-04-1519-01A
48 years, female, stage:Stage IIIC, alive, 24 days
2524.2
TCGA-13-0730-01A
71 years, female, white, stage:Stage IIIC, dead, 542 days
2508.6
TCGA-24-1567-01A
54 years, female, white, stage:Stage IIIB, dead, 524 days
2465.5
TCGA-57-1586-01A
66 years, female, white, stage:Stage IIIC, alive, 679 days
2445.2
TCGA-09-2048-01A
63 years, female, white, stage:Stage IIIC, dead, 138 days
2433.2
TCGA-13-0920-01A
65 years, female, white, stage:Stage IIIC, dead, 1484 days
2425.1
TCGA-09-1669-01A
54 years, female, white, stage:Stage IIIA, alive, 928 days
2398.8
TCGA-13-0888-01A
78 years, female, white, stage:Stage IIIC, dead, 2811 days
2394.8
TCGA-13-1404-01A
48 years, female, white, stage:Stage IIIC, alive, 2469 days
2373.3
TCGA-24-1431-01A
67 years, female, white, stage:Stage IIIC, dead, 583 days
2372.5
TCGA-20-1687-01A
46 years, female, white, stage:Stage IV, alive, 81 days
2358.3
TCGA-24-1924-01A
65 years, female, white, stage:Stage IIIC, dead, 919 days
2343.3
TCGA-25-1631-01A
73 years, female, white, stage:Stage IIIC, dead, 9 days
2337.9
TCGA-24-1434-01A
59 years, female, white, stage:Stage IIIC, dead, 568 days
2333.7
TCGA-30-1892-01A
52 years, female, white, stage:Stage IIIC, dead, 1484 days
2325.7
TCGA-61-1914-01A
65 years, female, stage:Stage IIIC, alive, 1722 days
2310.8
TCGA-09-0364-01A
80 years, female, white, stage:Stage IIC, dead, 887 days
2308.7
TCGA-24-1565-01A
74 years, female, white, stage:Stage IIIC, dead, 312 days
2308.7
TCGA-13-0797-01A
49 years, female, white, stage:Stage IIIC, alive, 2121 days
2303.5
TCGA-59-2355-01A
58 years, female, white, stage:Stage IV, dead, 65 days
2294.0
TCGA-36-1577-01A
43 years, female, asian, stage:Stage IIC, alive, 783 days
2291.6
TCGA-61-1907-01A
63 years, female, white, stage:Stage IIIC, alive, 952 days
2283.8
TCGA-24-0968-01A
59 years, female, white, stage:Stage IIIC, dead, 598 days
2264.0
TCGA-13-1510-01A
62 years, female, white, stage:Stage IIIC, dead, 1359 days
2259.0
TCGA-25-1328-01A
38 years, female, white, stage:Stage IIIC, dead, 2009 days
2251.8
TCGA-25-1870-01A
59 years, female, white, stage:Stage IIIC, dead, 455 days
2232.2
TCGA-24-1474-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 676 days
2226.3
TCGA-04-1542-01A
52 years, female, white, stage:Stage IIIB, dead, 2561 days
2196.2
TCGA-24-2033-01A
87 years, female, white, stage:Stage IIIC, dead, 562 days
2178.0
TCGA-29-1776-01A
63 years, female, black or african american, stage:Stage IIIC, alive, 360 days
2157.2
TCGA-24-1464-01A
70 years, female, white, stage:Stage IIIC, dead, 379 days
2157.1
TCGA-61-2101-01A
55 years, female, white, stage:Stage IIIC, dead, 1688 days
2147.3
TCGA-61-1733-01A
71 years, female, white, stage:Stage IIIC, alive, 967 days
2146.7
TCGA-24-2024-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
2124.0
TCGA-36-1568-01A
52 years, female, stage:Stage IIIC, alive, 875 days
2102.3
TCGA-30-1861-01A
74 years, female, white, stage:Stage IIIC, dead, 1058 days
2097.9
TCGA-29-2427-01A
60 years, female, white, stage:Stage IIIC, alive, 1900 days
2087.9
TCGA-13-2060-01A
51 years, female, white, stage:Stage IV, alive, 2369 days
2086.2
TCGA-24-1426-01A
43 years, female, white, stage:Stage IIIC, alive, 163 days
2079.3
TCGA-29-1783-01A
58 years, female, white, stage:Stage IIIC, alive, 220 days
2077.2
TCGA-23-1118-01A
45 years, female, white, stage:Stage IIIC, alive, 2616 days
2068.7
TCGA-61-2009-01A
65 years, female, white, stage:Stage IIIC, alive, 1212 days
2061.0
TCGA-61-1998-01A
48 years, female, white, stage:Stage IIIC, alive, 168 days
2050.5
TCGA-29-1691-01A
51 years, female, white, stage:Stage IIIC, dead, 1470 days
2049.7
TCGA-13-1509-01A
64 years, female, white, stage:Stage IV, alive, 2438 days
2038.8
TCGA-61-1995-01A
43 years, female, white, stage:Stage IIIC, alive, 61 days
2024.4
TCGA-59-2350-01A
44 years, female, stage:Stage IV, dead, 679 days
2022.6
TCGA-23-1109-01A
62 years, female, white, stage:Stage IIIC, dead, 1562 days
2020.6
TCGA-61-2109-01A
40 years, female, white, stage:Stage IIIC, dead, 629 days
2017.0
TCGA-24-1413-01A
51 years, female, white, stage:Stage IIIC, alive, 192 days
2013.5
TCGA-23-2077-01A
45 years, female, white, stage:Stage IIIC, alive, 3525 days
2011.7
TCGA-23-1024-01A
52 years, female, white, stage:Stage IV, alive, 468 days
2009.0
TCGA-25-2396-01A
71 years, female, white, stage:Stage IIIC, dead, 92 days
1991.3
TCGA-29-1697-01A
62 years, female, white, stage:Stage IIIC, dead, 949 days
1985.2
TCGA-10-0928-01A
71 years, female, white, stage:Stage IIIC, dead, 563 days
1977.3
TCGA-04-1364-01A
61 years, female, white, stage:Stage IIIC, dead, 1024 days
1969.7
TCGA-24-1428-01A
50 years, female, white, stage:Stage IIIC, alive, 529 days
1965.6
TCGA-29-1785-01A
55 years, female, white, stage:Stage IIIC, dead, 1104 days
1959.5
TCGA-13-1477-01A
49 years, female, white, stage:Stage IV, dead, 1662 days
1948.5
TCGA-13-1501-01A
50 years, female, white, stage:Stage IV, dead, 1314 days
1942.0
TCGA-13-1495-01A
60 years, female, white, stage:Stage IIIC, dead, 2749 days
1932.7
TCGA-36-1580-01A
82 years, female, stage:Stage IIIC, dead, 737 days
1925.1
TCGA-29-1762-01A
59 years, female, white, stage:Stage IV, dead, 2634 days
1924.9
TCGA-20-1686-01A
75 years, female, white, stage:Stage IIIC, alive, 89 days
1916.9
TCGA-61-2002-01A
46 years, female, white, stage:Stage IIIC, alive, 547 days
1911.3
TCGA-24-1467-01A
51 years, female, white, stage:Stage IIIC, dead, 3224 days
1903.9
TCGA-57-1583-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 346 days
1889.7
TCGA-09-1673-01A
50 years, female, white, stage:Stage IV, alive, 92 days
1887.2
TCGA-61-2000-01A
67 years, female, white, stage:Stage IIIC, alive, 441 days
1877.0
TCGA-20-0987-01A
61 years, female, white, stage:Stage IIIC, dead, 701 days
1873.4
TCGA-36-1571-01A
53 years, female, white, stage:Stage IIIB, dead, 695 days
1869.1
TCGA-61-2097-01A
71 years, female, white, stage:Stage IIC, alive, 1844 days
1868.4
TCGA-24-1845-01A
42 years, female, white, stage:Stage IIIC, alive, 116 days
1868.3
TCGA-13-0714-01A
55 years, female, white, stage:Stage IV, dead, 189 days
1863.6
TCGA-23-2078-01A
66 years, female, white, stage:Stage IIIC, alive, 2661 days
1853.1
TCGA-04-1514-01A
45 years, female, white, stage:Stage IIIA, dead, 1720 days
1845.9
TCGA-29-1694-01A
45 years, female, white, stage:Stage IIIC, dead, 1187 days
1843.8
TCGA-13-1408-01A
59 years, female, white, stage:Stage IIIC, dead, 1680 days
1834.7
TCGA-13-0906-01A
50 years, female, white, stage:Stage IIIC, alive, 3619 days
1816.2
TCGA-23-2084-01A
45 years, female, white, stage:Stage IV, dead, 1516 days
1786.2
TCGA-59-A5PD-01A
55 years, female, black or african american, stage:Stage IC, dead, 624 days
1771.5
TCGA-23-1030-01A
64 years, female, white, stage:Stage IIIC, alive, 886 days
1771.4
TCGA-13-0726-01A
55 years, female, white, stage:Stage IIIC, dead, 949 days
1770.3
TCGA-59-2351-01A
51 years, female, white, stage:Stage IIIC, alive, 3532 days
1761.2
TCGA-36-1570-01A
49 years, female, white, stage:Stage IIIC, alive, 655 days
1758.4
TCGA-24-1416-01A
34 years, female, white, stage:Stage IV, alive, 194 days
1756.3
TCGA-24-1422-01A
82 years, female, black or african american, stage:Stage IIIC, dead, 23 days
1752.7
TCGA-13-1483-01A
61 years, female, white, stage:Stage IIIC, dead, 895 days
1747.3
TCGA-61-2111-01A
61 years, female, white, stage:Stage IV, alive, 3825 days
1742.6
TCGA-24-2280-01A
74 years, female, white, stage:Stage IIIC, alive, 2143 days
1739.1
TCGA-24-0979-01A
53 years, female, white, stage:Stage IV, dead, 1264 days
1732.5
TCGA-61-2092-01A
57 years, female, white, stage:Stage IIIC, alive, 1573 days
1731.6
TCGA-23-1116-01A
83 years, female, white, stage:Stage IIIC, dead, 592 days
1714.0
TCGA-29-1763-01A
43 years, female, black or african american, stage:Stage IIC, alive, 2032 days
1694.5
TCGA-61-1900-01A
51 years, female, black or african american, stage:Stage IIIB, alive, 176 days
1677.9
TCGA-24-2267-01A
58 years, female, white, stage:Stage IIB, dead, 1446 days
1676.4
TCGA-04-1332-01A
70 years, female, white, stage:Stage IIIC, dead, 1247 days
1671.5
TCGA-29-1705-01A
47 years, female, white, stage:Stage IIIC, dead, 555 days
1669.4
TCGA-61-1738-01A
60 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
1667.8
TCGA-13-1506-01A
45 years, female, white, stage:Stage IIIC, dead, 1039 days
1649.8
TCGA-24-2035-01A
65 years, female, white, stage:Stage IIIC, dead, 857 days
1646.7
TCGA-24-1846-01A
45 years, female, stage:Stage IIIC, alive, 133 days
1640.4
TCGA-24-2254-01A
66 years, female, white, stage:Stage IIIC, dead, 1736 days
1632.8
TCGA-57-1584-01A
47 years, female, white, stage:Stage IIIC, alive, 643 days
1632.3
TCGA-25-1623-01A
71 years, female, white, stage:Stage IV, dead, 565 days
1629.4
TCGA-23-1023-01A
65 years, female, white, stage:Stage IIIC, alive, 1233 days
1620.0
TCGA-24-1604-01A
66 years, female, white, stage:Stage IIIC, dead, 2688 days
1618.2
TCGA-61-1724-01A
47 years, female, white, stage:Stage IIIC, dead, 637 days
1594.9
TCGA-61-2098-01A
62 years, female, white, stage:Stage IIIC, alive, 1993 days
1575.5
TCGA-57-1585-01A
57 years, female, white, stage:Stage IIIC, dead, 53 days
1567.8
TCGA-61-1741-01A
76 years, female, white, stage:Stage IIIB, dead, 1024 days
1563.3
TCGA-24-2261-01A
76 years, female, white, stage:Stage IIIC, dead, 24 days
1553.4
TCGA-61-2008-01A
40 years, female, asian, stage:Stage IIC, alive, 932 days
1549.1
TCGA-31-1956-01A
60 years, female, white, stage:Stage IIIB, alive, 1342 days
1539.2
TCGA-24-1850-01A
72 years, female, white, stage:Stage IIIC, alive, 168 days
1538.9
TCGA-25-1312-01A
69 years, female, white, stage:Stage IV, dead, 31 days
1534.2
TCGA-25-1321-01A
65 years, female, white, stage:Stage IIIC, dead, 1033 days
1530.8
TCGA-24-2281-01A
68 years, female, white, stage:Stage IIA, alive, 1357 days
1527.6
TCGA-61-1737-01A
42 years, female, white, stage:Stage IV, alive, 1364 days
1523.5
TCGA-25-1313-01A
62 years, female, white, stage:Stage IV, dead, 820 days
1520.2
TCGA-24-1552-01A
77 years, female, white, stage:Stage IIIC, dead, 1259 days
1517.2
TCGA-23-1122-01A
53 years, female, white, stage:Stage IIIC, dead, 1189 days
1514.9
TCGA-24-2288-01A
70 years, female, white, stage:Stage IIIC, dead, 25 days
1512.4
TCGA-57-1582-01A
50 years, female, white, stage:Stage IIIC, dead, 731 days
1511.4
TCGA-13-1512-01A
49 years, female, white, stage:Stage IIIC, alive, 442 days
1497.6
TCGA-30-1860-01A
58 years, female, white, stage:Stage IIIC, dead, 1366 days
1487.9
TCGA-24-2020-01A
67 years, female, white, stage:Stage IIIC, dead, 4624 days
1481.7
TCGA-04-1362-01A
59 years, female, white, stage:Stage IIC, dead, 1348 days
1479.5
TCGA-29-A5NZ-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
1466.3
TCGA-24-2023-01A
54 years, female, white, stage:Stage IIIA, dead, 1364 days
1455.7
TCGA-09-1662-01A
58 years, female, white, stage:Stage IV, dead, 2717 days
1443.7
TCGA-61-1919-01A
58 years, female, white, stage:Stage IIIC, dead, 1161 days
1442.9
TCGA-09-0369-01A
56 years, female, white, stage:Stage IIIC, dead, 1082 days
1439.5
TCGA-59-2352-01A
78 years, female, white, stage:Stage IIIC, dead, 286 days
1429.0
TCGA-13-1496-01A
65 years, female, white, stage:Stage IIIC, dead, 129 days
1423.5
TCGA-13-0911-01A
55 years, female, white, stage:Stage IV, dead, 1355 days
1422.4
TCGA-24-1550-01A
49 years, female, white, stage:Stage IIIC, dead, 1249 days
1410.5
TCGA-29-1770-01A
54 years, female, white, stage:Stage IIIC, alive, 741 days
1410.4
TCGA-24-2298-01A
55 years, female, white, stage:Stage IIIC, dead, 1620 days
1409.3
TCGA-24-0982-01A
77 years, female, white, stage:Stage IIIC, dead, 679 days
1405.7
TCGA-09-2051-01A
42 years, female, white, stage:Stage IIIC, alive, 1919 days
1400.9
TCGA-13-0897-01A
54 years, female, white, stage:Stage IIIC, dead, 2182 days
1392.8
TCGA-13-1488-01A
59 years, female, white, stage:Stage IV, dead, 2154 days
1388.9
TCGA-30-1866-01A
61 years, female, white, stage:Stage IV, dead, 1114 days
1388.4
TCGA-31-1944-01A
47 years, female, white, stage:Stage IIIC, alive, 1386 days
1382.5
TCGA-24-1418-01A
68 years, female, white, stage:Stage IIIC, alive, 243 days
1379.4
TCGA-31-1959-01A
49 years, female, white, stage:Stage IV, alive, 67 days
1365.8
TCGA-25-2401-01A
64 years, female, white, stage:Stage IIIC, dead, 90 days
1360.9
TCGA-29-1774-01A
82 years, female, white, stage:Stage IIIC, alive, 527 days
1353.7
TCGA-61-1911-01A
55 years, female, white, stage:Stage IIA, alive, 1293 days
1349.0
TCGA-25-2399-01A
80 years, female, white, stage:Stage IIIC, dead, 608 days
1346.2
TCGA-24-1419-01A
62 years, female, white, stage:Stage IIIC, alive, 239 days
1335.3
TCGA-57-1994-01A
63 years, female, white, stage:'--, alive, 761 days
1330.5
TCGA-13-1407-01A
51 years, female, white, stage:Stage IIIC, alive, 2534 days
1328.8
TCGA-04-1530-01A
68 years, female, white, stage:Stage IIIC, dead, 3622 days
1317.4
TCGA-13-1485-01A
48 years, female, white, stage:Stage IV, dead, 629 days
1317.1
TCGA-25-1626-01A
65 years, female, white, stage:Stage IIIC, dead, 518 days
1316.8
TCGA-13-1499-01A
56 years, female, white, stage:Stage IIIC, alive, 3500 days
1314.6
TCGA-24-1844-01A
64 years, female, white, stage:Stage IIIC, alive, 113 days
1314.5
TCGA-36-1574-01A
48 years, female, asian, stage:Stage IIIC, alive, 686 days
1308.8
TCGA-04-1361-01A
57 years, female, white, stage:Stage IIIB, alive, 989 days
1303.7
TCGA-24-1563-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
1289.9
TCGA-23-1110-01A
42 years, female, white, stage:Stage IIIC, alive, 1658 days
1286.5
TCGA-25-1627-01A
73 years, female, white, stage:Stage IIIC, dead, 394 days
1279.4
TCGA-24-2290-01A
56 years, female, white, stage:Stage IIIC, dead, 1102 days
1274.7
TCGA-24-1435-01A
57 years, female, white, stage:Stage IIIC, dead, 1324 days
1270.7
TCGA-29-1781-01A
69 years, female, white, stage:Stage IIIC, alive, 255 days
1270.3
TCGA-24-1417-01A
54 years, female, white, stage:Stage IV, alive, 238 days
1268.7
TCGA-13-1497-01A
47 years, female, white, stage:Stage IIIC, alive, 3871 days
1267.4
TCGA-13-0916-01A
49 years, female, white, stage:Stage IIIC, alive, 1785 days
1266.7
TCGA-23-1123-01A
59 years, female, white, stage:Stage IIIC, dead, 1018 days
1263.4
TCGA-24-1424-01A
67 years, female, white, stage:Stage IIIC, alive, 183 days
1261.6
TCGA-25-1315-01A
50 years, female, white, stage:Stage IIIC, dead, 1583 days
1261.5
TCGA-24-1843-01A
66 years, female, white, stage:Stage IIIC, alive, 106 days
1255.3
TCGA-29-1710-01A
54 years, female, white, stage:Stage IIIC, dead, 951 days
1237.4
TCGA-29-1784-01A
55 years, female, white, stage:Stage IIIC, alive, 163 days
1231.2
TCGA-61-1918-01A
45 years, female, white, stage:Stage IV, dead, 479 days
1229.4
TCGA-29-1778-01A
77 years, female, white, stage:Stage IIIC, alive, 454 days
1224.8
TCGA-09-2054-01A
58 years, female, black or african american, stage:Stage IIIC, dead, 637 days
1223.6
TCGA-23-1119-01A
64 years, female, white, stage:Stage IIIC, alive, 3953 days
1222.3
TCGA-25-2409-01A
71 years, female, white, stage:Stage IV, dead, 821 days
1212.5
TCGA-20-0991-01A
78 years, female, white, stage:Stage IIB, alive, 797 days
1208.1
TCGA-09-0366-01A
55 years, female, white, stage:Stage IIIC, dead, 1757 days
1185.6
TCGA-13-1403-01A
48 years, female, white, stage:Stage IIIC, dead, 2345 days
1182.2
TCGA-61-2003-01A
53 years, female, white, stage:Stage IIIC, alive, 122 days
1177.2
TCGA-24-1928-01A
77 years, female, white, stage:Stage IIIC, dead, 336 days
1174.7
TCGA-59-2354-01A
63 years, female, white, stage:Stage IIIC, dead, 1046 days
1171.9
TCGA-24-1469-01A
71 years, female, white, stage:Stage IIIC, alive, 277 days
1161.9
TCGA-24-1427-01A
58 years, female, stage:Stage IIIC, alive, 147 days
1155.3
TCGA-24-1103-01A
50 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
1153.6
TCGA-24-1603-01A
53 years, female, white, stage:Stage IIIB, dead, 2742 days
1145.4
TCGA-24-1430-01A
68 years, female, white, stage:Stage IIIC, dead, 863 days
1144.6
TCGA-04-1365-01A
87 years, female, white, stage:Stage IIIB, alive, 947 days
1142.4
TCGA-04-1651-01A
53 years, female, white, stage:Stage IIIC, dead, 1102 days
1140.0
TCGA-29-2428-01A
58 years, female, white, stage:Stage IIIC, alive, 1372 days
1138.2
TCGA-25-2404-01A
38 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
1131.0
TCGA-23-1809-01A
63 years, female, white, stage:Stage IIC, alive, 16 days
1128.7
TCGA-61-2113-01A
53 years, female, white, stage:Stage IIC, dead, 676 days
1123.1
TCGA-09-2045-01A
50 years, female, asian, stage:Stage IV, dead, 1069 days
1122.5
TCGA-24-1930-01A
53 years, female, white, stage:Stage IIIC, dead, 2467 days
1114.6
TCGA-30-1857-01A
64 years, female, white, stage:Stage IV, dead, 8 days
1110.5
TCGA-25-1323-01A
72 years, female, white, stage:Stage IIIC, dead, 395 days
1105.5
TCGA-24-2293-01A
47 years, female, white, stage:'--, dead, 506 days
1103.1
TCGA-31-1946-01A
30 years, female, stage:Stage IIIC, alive, 918 days
1101.2
TCGA-24-2027-01A
51 years, female, white, stage:Stage IV, dead, 3337 days
1097.1
TCGA-29-1695-01A
62 years, female, white, stage:Stage IIIC, dead, 1229 days
1094.3
TCGA-24-1425-01A
45 years, female, white, stage:Stage IIIC, alive, 181 days
1079.1
TCGA-04-1338-01A
78 years, female, white, stage:Stage IIIC, alive, 1418 days
1077.4
TCGA-31-1951-01A
58 years, female, white, stage:Stage IIIC, alive, 684 days
1074.7
TCGA-25-1628-01A
67 years, female, white, stage:Stage IIIC, dead, 627 days
1070.0
TCGA-36-1576-01A
76 years, female, stage:Stage IIIC, alive, 915 days
1064.6
TCGA-25-1318-01A
54 years, female, white, stage:Stage IIIC, dead, 1064 days
1062.1
TCGA-13-1405-01A
49 years, female, white, stage:Stage IV, dead, 868 days
1057.5
TCGA-29-1688-01A
39 years, female, white, stage:Stage IIIC, dead, 2400 days
1057.5
TCGA-25-2042-01A
60 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
1048.8
TCGA-29-1711-01A
45 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
1045.1
TCGA-59-2348-01A
59 years, female, white, stage:Stage IIIC, alive, 5481 days
1042.4
TCGA-25-1326-01A
61 years, female, white, stage:Stage IIIC, dead, 1249 days
1039.9
TCGA-04-1536-01A
60 years, female, black or african american, stage:Stage IV, dead, 885 days
1039.0
TCGA-24-1104-01A
56 years, female, white, stage:Stage IV, dead, 1933 days
1034.1
TCGA-20-1683-01A
65 years, female, white, stage:Stage IIIC, alive, 772 days
1028.8
TCGA-61-2088-01A
51 years, female, white, stage:Stage IIIC, alive, 145 days
1025.1
TCGA-04-1648-01A
57 years, female, white, stage:Stage IIIC, dead, 871 days
1023.8
TCGA-10-0933-01A
77 years, female, white, stage:Stage IIIC, dead, 446 days
1005.6
TCGA-13-0725-01A
44 years, female, white, stage:Stage IIIC, dead, 377 days
1005.5
TCGA-24-2297-01A
56 years, female, white, stage:Stage IIIC, dead, 1699 days
1003.0
TCGA-20-1682-01A
56 years, female, white, stage:Stage IIIC, alive, 837 days
988.5
TCGA-24-1551-01A
53 years, female, white, stage:Stage IIIC, dead, 1579 days
978.3
TCGA-25-1635-01A
71 years, female, white, stage:Stage IIIC, dead, 1583 days
975.5
TCGA-13-0886-01A
67 years, female, white, stage:Stage IIIC, alive, 4665 days
973.2
TCGA-13-0891-01A
73 years, female, white, stage:Stage IV, dead, 3128 days
969.6
TCGA-25-1320-01A
65 years, female, white, stage:Stage IIIC, dead, 1155 days
956.4
TCGA-61-1910-01A
56 years, female, white, stage:Stage IIC, alive, 1127 days
955.0
TCGA-13-1498-01A
73 years, female, white, stage:Stage IIIC, dead, 2012 days
951.6
TCGA-13-0720-01A
48 years, female, white, stage:Stage IIIC, dead, 1355 days
944.9
TCGA-23-1028-01A
43 years, female, white, stage:Stage IIIC, alive, 1503 days
941.0
TCGA-13-0800-01A
52 years, female, white, stage:Stage IIIC, alive, 2661 days
930.3
TCGA-24-1546-01A
46 years, female, white, stage:Stage IIIC, dead, 1955 days
930.2
TCGA-25-2392-01A
75 years, female, white, stage:Stage IV, dead, 31 days
929.3
TCGA-13-1411-01A
81 years, female, white, stage:Stage IIIC, dead, 531 days
926.7
TCGA-31-1953-01A
52 years, female, asian, stage:Stage IIIC, alive, 204 days
923.5
TCGA-25-1329-01A
76 years, female, white, stage:Stage IIIC, dead, 457 days
915.0
TCGA-23-1120-01A
60 years, female, white, stage:Stage IIIC, alive, 130 days
912.1
TCGA-04-1331-01A
78 years, female, white, stage:Stage IIIC, dead, 1336 days
907.2
TCGA-25-2398-01A
71 years, female, white, stage:Stage IIIC, dead, 1369 days
900.7
TCGA-24-2036-01A
50 years, female, white, stage:Stage IIIA, dead, 1947 days
900.6
TCGA-13-1410-01A
57 years, female, white, stage:Stage IV, alive, 2464 days
892.4
TCGA-13-1492-01A
66 years, female, white, stage:Stage IIIC, dead, 3819 days
890.4
TCGA-29-1693-01A
72 years, female, white, stage:Stage IIIC, alive, 3096 days
882.9
TCGA-24-1558-01A
73 years, female, white, stage:Stage IIIC, dead, 594 days
882.8
TCGA-57-1993-01A
56 years, female, white, stage:Stage IIIC, alive, 763 days
881.2
TCGA-24-2026-01A
79 years, female, white, stage:Stage IIIC, dead, 1059 days
869.1
TCGA-24-1105-01A
36 years, female, white, stage:Stage IIIC, dead, 1442 days
853.2
TCGA-13-0768-01A
73 years, female, white, stage:Stage IIIC, dead, 1784 days
851.0
TCGA-25-1322-01A
62 years, female, white, stage:Stage IV, dead, 91 days
841.9
TCGA-24-1847-01A
45 years, female, white, stage:Stage IV, alive, 343 days
830.0
TCGA-24-1423-01A
61 years, female, white, stage:Stage IIIC, alive, 190 days
821.7
TCGA-61-2104-01A
53 years, female, white, stage:Stage IIC, alive, 2338 days
816.3
TCGA-24-1557-01A
49 years, female, white, stage:Stage IIIC, dead, 1213 days
804.2
TCGA-61-2012-01A
81 years, female, white, stage:Stage IIC, alive, 932 days
802.9
TCGA-24-2271-01A
55 years, female, asian, stage:Stage IIIC, dead, 962 days
783.7
TCGA-24-1549-01A
58 years, female, white, stage:Stage IIIB, dead, 1721 days
771.9
TCGA-24-2289-01A
68 years, female, white, stage:Stage IV, dead, 2049 days
761.5
TCGA-31-1950-01A
76 years, female, white, stage:Stage IIIC, alive, 571 days
727.3
TCGA-61-2102-01A
74 years, female, white, stage:Stage IIIC, dead, 197 days
710.6
TCGA-25-1319-01A
73 years, female, white, stage:Stage IIIC, dead, 1977 days
694.8
TCGA-13-1511-01A
52 years, female, asian, stage:Stage IV, dead, 1650 days
661.8
TCGA-36-1581-01A
63 years, female, white, stage:Stage IIC, alive, 751 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL31 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
3293.2
Number of samples
81
Samples
Sample
Description
pTPM
DO46338
59 years, female, NA, stage:III, dead, 596 days
9805.2
DO46356
68 years, female, NA, stage:III, dead, 911 days
8294.4
DO46390
65 years, female, NA, stage:III, dead, 374 days
8082.2
DO46384
55 years, female, NA, stage:III, dead, 614 days
7648.3
DO46561
52 years, female, NA, stage:III, dead, 195 days
6777.5
DO46370
54 years, female, NA, stage:III, dead, 1727 days
6684.4
DO46568
66 years, female, NA, stage:III, dead, 320 days
6185.6
DO46326
51 years, female, NA, stage:III, dead, 701 days
5365.4
DO46523
52 years, female, NA, stage:IV, alive, 1873 days
5343.5
DO46402
77 years, female, NA, stage:III, dead, 511 days
5294.6
DO46334
77 years, female, NA, stage:III, dead, 496 days
5122.2
DO46360
58 years, female, NA, stage:IV, dead, 1759 days
4956.1
DO46463
49 years, female, NA, stage:III, dead, 2451 days
4776.3
DO46443
59 years, female, NA, stage:III, dead, 2464 days
4646.7
DO46362
61 years, female, NA, stage:III, dead, 1639 days
4202.2
DO46591
58 years, female, NA, stage:III, dead, 195 days
4181.2
DO46328
52 years, female, NA, stage:III, dead, 972 days
4090.4
DO46581
66 years, female, NA, stage:III, dead, 408 days
4049.3
DO46408
56 years, female, NA, stage:III, dead, 489 days
3940.2
DO46597
60 years, female, NA, stage:III, dead, 393 days
3930.3
DO46364
45 years, female, NA, stage:III, dead, 806 days
3896.7
DO46398
66 years, female, NA, stage:III, alive, 437 days
3819.7
DO46358
60 years, female, NA, stage:III, dead, 423 days
3786.7
DO46400
70 years, female, NA, stage:III, dead, 719 days
3780.6
DO46404
55 years, female, NA, stage:III, dead, 690 days
3733.9
DO46508
50 years, female, NA, stage:III, dead, 2101 days
3717.6
DO46533
46 years, female, NA, stage:III, alive, 3667 days
3648.0
DO46588
74 years, female, NA, stage:III, dead, 438 days
3589.3
DO46378
59 years, female, NA, stage:III, alive, 843 days
3583.6
DO46331
72 years, female, NA, stage:III, dead, 612 days
3514.3
DO46566
78 years, female, NA, stage:III, dead, 673 days
3434.0
DO46392
48 years, female, NA, stage:III, dead, 628 days
3433.1
DO46386
49 years, female, NA, stage:III, dead, 1162 days
3361.1
DO46560
45 years, female, NA, stage:IV, dead, 286 days
3357.4
DO46586
55 years, female, NA, stage:III, dead, 1019 days
3336.4
DO46576
75 years, female, NA, stage:III, alive, 133 days
3249.2
DO46448
45 years, female, NA, stage:III, dead, 654 days
3215.8
DO46330
60 years, female, NA, stage:III, dead, 684 days
3200.7
DO46493
62 years, female, NA, stage:IV, alive, 839 days
3126.5
DO46394
61 years, female, NA, stage:IV, dead, 1039 days
3043.6
DO46333
58 years, female, NA, stage:III, dead, 359 days
3042.4
DO46388
74 years, female, NA, stage:III, dead, 413 days
3036.7
DO46352
60 years, female, NA, stage:III, dead, 677 days
3019.5
DO46518
62 years, female, NA, stage:III, alive, 2960 days
2957.4
DO46453
66 years, female, NA, stage:III, dead, 3294 days
2926.0
DO46438
55 years, female, NA, stage:IV, alive, 2227 days
2774.2
DO46342
67 years, female, NA, stage:III, dead, 1398 days
2668.8
DO46325
54 years, female, NA, stage:III, dead, 477 days
2617.6
DO46376
58 years, female, NA, stage:III, dead, 1430 days
2549.1
DO46538
57 years, female, NA, stage:III, dead, 1527 days
2496.1
DO46606
73 years, female, NA, stage:III, alive, 804 days
2468.7
DO46458
67 years, female, NA, stage:IV, alive, 3787 days
2436.1
DO46348
58 years, female, NA, stage:IV, dead, 287 days
2420.9
DO46354
73 years, female, NA, stage:III, dead, 843 days
2391.5
DO46513
54 years, female, NA, stage:IV, dead, 1883 days
2322.9
DO46346
54 years, female, NA, stage:III, dead, 1187 days
2223.0
DO46432
56 years, female, NA, stage:III, alive, 2218 days
2168.6
DO46340
62 years, female, NA, stage:III, dead, 616 days
2136.9
DO46436
58 years, female, NA, stage:III, alive, 3193 days
2077.5
DO46602
74 years, female, NA, stage:III, dead, 205 days
2066.9
DO46611
52 years, female, NA, stage:III, dead, 734 days
1992.3
DO46382
62 years, female, NA, stage:IV, dead, 311 days
1989.6
DO46528
56 years, female, NA, stage:III, alive, 6139 days
1953.7
DO46412
64 years, female, NA, stage:III, dead, 597 days
1933.9
DO46396
64 years, female, NA, stage:III, dead, 583 days
1885.6
DO46368
57 years, female, NA, stage:III, dead, 2879 days
1845.8
DO46366
65 years, female, NA, stage:III, dead, 2054 days
1764.2
DO46546
73 years, female, NA, stage:III, dead, 1889 days
1669.6
DO46380
51 years, female, NA, stage:III, dead, 1423 days
1666.8
DO46332
56 years, female, NA, stage:III, dead, 689 days
1656.6
DO46327
54 years, female, NA, stage:III, dead, 184 days
1621.4
DO46344
46 years, female, NA, stage:III, dead, 642 days
1583.5
DO46372
39 years, female, NA, stage:III, dead, 1326 days
1580.8
DO46468
67 years, female, NA, stage:III, alive, 2776 days
1546.6
DO46374
69 years, female, NA, stage:III, dead, 1409 days
1522.7
DO46551
58 years, female, NA, stage:III, dead, 1055 days
1522.4
DO46350
66 years, female, NA, stage:III, dead, 886 days
1433.5
DO46571
61 years, female, NA, stage:III, dead, 243 days
1387.8
DO46329
52 years, female, NA, stage:III, dead, 1699 days
778.3
DO46336
70 years, female, NA, stage:IV, dead, 664 days
752.5
DO46428
59 years, female, NA, stage:IV, alive, 2644 days
659.7
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
1.9
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
1.7
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
1.7
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
1.7
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
1.6
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
1.4
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
1.4
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
1.4
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
1.4
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
1.3
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
1.3
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
1.3
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
1.3
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
1.2
285fed94-1495-448e-879b-b55de9_D2
Tumor
1.2
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
1.2
15524912-685a-47ce-a824-567848_D2
Tumor
1.2
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
1.2
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
1.2
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
1.2
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
1.2
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
1.1
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
1.1
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
1.1
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
1.1
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
1.1
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
1.1
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
1.0
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
1.0
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
1.0
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
1.0
2f901c90-617e-46da-9fac-d68369_D2
Tumor
1.0
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
1.0
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
1.0
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
1.0
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
0.9
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
0.9
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.9
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.9
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.9
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.9
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
0.8
e9d416e7-f661-400a-896e-388545_D2
Tumor
0.8
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.8
10c2d629-0287-4511-ac25-f29031_D2
Tumor
0.7
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.7
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.7
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
0.7
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
0.6
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.6
161317f3-1a39-438e-af45-cd2502_D2
Tumor
0.6
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.6
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.6
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
0.6
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.5
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
0.5
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.5
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.5
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
0.5
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.5
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.5
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
0.5
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
0.4
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
0.4
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
0.4
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.4
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
0.3
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
0.3
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.3
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
0.3
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
0.3
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.2
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
0.2
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
0.1
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
0.1
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
0.1
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
0.1
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
0.1
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
0.0
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
0.0
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
0.0
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
0.0
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
-0.1
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
-0.1
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
-0.2
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
-0.2
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-0.2
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-0.2
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-0.2
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.3
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-0.4
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-0.4
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.4
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
-0.4
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.4
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.5
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.5
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.5
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-0.5
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.5
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
-0.5
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-0.6
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-0.7
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.7
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
-0.7
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.9
a3a26070-fb84-406a-8280-d555e6_D2
Normal
-1.2
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-1.3
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
The Human Protein Atlas project is funded
